US Stock MarketDetailed Quotes

MXRX Med-X

Watchlist
  • 4.000
  • 0.0000.00%
Close Nov 1 16:00 ET
21.49MMarket Cap-3.03P/E (TTM)

Med-X Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.82%-1.27M
-9.41%-4.88M
-982.32K
-1.84M
-35.07%-4.46M
-3.3M
Net income from continuing operations
22.16%-1.13M
-47.66%-7.34M
---2.96M
---1.45M
-40.36%-4.97M
---3.54M
Operating gains losses
----
----
----
----
---319.61K
----
Depreciation and amortization
79.22%10.18K
-27.19%29.04K
--10.42K
--5.68K
-64.67%39.89K
--112.9K
Other non cash items
-83.33%1.8K
78.85%1.91M
--1.89M
--10.78K
191.66%1.07M
--366.59K
Change In working capital
61.81%-153.81K
281.61%511.41K
--82.17K
---402.72K
-17.18%-281.6K
---240.3K
-Change in receivables
83.39%-17.84K
-130.01%-36.68K
---9.86K
---107.43K
225.46%122.23K
---97.43K
-Change in inventory
326.14%95.2K
179.53%162.12K
---15.3K
---42.1K
-2,254.85%-203.84K
---8.66K
-Change in prepaid assets
88.62%-21.93K
141.42%69.54K
---33.37K
---192.8K
-411.24%-167.89K
--53.94K
-Change in payables and accrued expense
-246.45%-209.24K
1,085.69%316.44K
--140.7K
---60.39K
82.94%-32.1K
---188.16K
Cash from discontinued investing activities
Operating cash flow
30.82%-1.27M
-9.41%-4.88M
---982.32K
---1.84M
-35.07%-4.46M
---3.3M
Investing cash flow
Cash flow from continuing investing activities
-241.88%-48.71K
1,004.45%34.33K
-3.8K
Net PPE purchase and sale
----
-241.88%-48.71K
----
----
1,004.45%34.33K
---3.8K
Cash from discontinued investing activities
Investing cash flow
--0
-241.88%-48.71K
---48.71K
--0
1,004.45%34.33K
---3.8K
Financing cash flow
Cash flow from continuing financing activities
12.06%1.27M
-25.20%3.77M
841.44K
1.13M
31.47%5.04M
3.83M
Net issuance payments of debt
-104.98%-3.95K
770.39%523.99K
--12.57K
--79.41K
-125.48%-78.16K
--306.71K
Net common stock issuance
20.87%1.27M
-36.58%3.25M
--828.87K
--1.05M
45.12%5.12M
--3.53M
Cash from discontinued financing activities
Financing cash flow
12.06%1.27M
-25.20%3.77M
--841.44K
--1.13M
31.47%5.04M
--3.83M
Net cash flow
Beginning cash position
-84.68%209.47K
81.62%1.37M
--662.88K
--1.37M
234.61%752.82K
--224.98K
Current changes in cash
99.82%-1.27K
-288.43%-1.16M
---189.59K
---704.4K
16.41%614.46K
--527.84K
End cash Position
-68.59%208.21K
-84.68%209.47K
--473.38K
--662.88K
81.62%1.37M
--752.82K
Free cash flow
30.82%-1.27M
-10.46%-4.93M
---1.03M
---1.84M
-34.96%-4.46M
---3.31M
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.82%-1.27M-9.41%-4.88M-982.32K-1.84M-35.07%-4.46M-3.3M
Net income from continuing operations 22.16%-1.13M-47.66%-7.34M---2.96M---1.45M-40.36%-4.97M---3.54M
Operating gains losses -------------------319.61K----
Depreciation and amortization 79.22%10.18K-27.19%29.04K--10.42K--5.68K-64.67%39.89K--112.9K
Other non cash items -83.33%1.8K78.85%1.91M--1.89M--10.78K191.66%1.07M--366.59K
Change In working capital 61.81%-153.81K281.61%511.41K--82.17K---402.72K-17.18%-281.6K---240.3K
-Change in receivables 83.39%-17.84K-130.01%-36.68K---9.86K---107.43K225.46%122.23K---97.43K
-Change in inventory 326.14%95.2K179.53%162.12K---15.3K---42.1K-2,254.85%-203.84K---8.66K
-Change in prepaid assets 88.62%-21.93K141.42%69.54K---33.37K---192.8K-411.24%-167.89K--53.94K
-Change in payables and accrued expense -246.45%-209.24K1,085.69%316.44K--140.7K---60.39K82.94%-32.1K---188.16K
Cash from discontinued investing activities
Operating cash flow 30.82%-1.27M-9.41%-4.88M---982.32K---1.84M-35.07%-4.46M---3.3M
Investing cash flow
Cash flow from continuing investing activities -241.88%-48.71K1,004.45%34.33K-3.8K
Net PPE purchase and sale -----241.88%-48.71K--------1,004.45%34.33K---3.8K
Cash from discontinued investing activities
Investing cash flow --0-241.88%-48.71K---48.71K--01,004.45%34.33K---3.8K
Financing cash flow
Cash flow from continuing financing activities 12.06%1.27M-25.20%3.77M841.44K1.13M31.47%5.04M3.83M
Net issuance payments of debt -104.98%-3.95K770.39%523.99K--12.57K--79.41K-125.48%-78.16K--306.71K
Net common stock issuance 20.87%1.27M-36.58%3.25M--828.87K--1.05M45.12%5.12M--3.53M
Cash from discontinued financing activities
Financing cash flow 12.06%1.27M-25.20%3.77M--841.44K--1.13M31.47%5.04M--3.83M
Net cash flow
Beginning cash position -84.68%209.47K81.62%1.37M--662.88K--1.37M234.61%752.82K--224.98K
Current changes in cash 99.82%-1.27K-288.43%-1.16M---189.59K---704.4K16.41%614.46K--527.84K
End cash Position -68.59%208.21K-84.68%209.47K--473.38K--662.88K81.62%1.37M--752.82K
Free cash flow 30.82%-1.27M-10.46%-4.93M---1.03M---1.84M-34.96%-4.46M---3.31M
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List